Order Article Reprints

Tupini C, Chilin A, Rossi A, De Fino I, Bragonzi A, D’Aversa E, Cosenza LC, Vaccarin C, Sacchetti G, Borgatti M, et al. New TMA (4,6,4′-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease. International Journal of Molecular Sciences. 2022; 23(22):14483. https://doi.org/10.3390/ijms232214483

Tupini, Chiara, Adriana Chilin, Alice Rossi, Ida De Fino, Alessandra Bragonzi, Elisabetta D’Aversa, Lucia Carmela Cosenza, Christian Vaccarin, Gianni Sacchetti, Monica Borgatti, and et al. 2022. "New TMA (4,6,4′-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease" International Journal of Molecular Sciences 23, no. 22: 14483. https://doi.org/10.3390/ijms232214483

Tupini, C., Chilin, A., Rossi, A., De Fino, I., Bragonzi, A., D’Aversa, E., Cosenza, L. C., Vaccarin, C., Sacchetti, G., Borgatti, M., Tamanini, A., Dechecchi, M. C., Sanvito, F., Gambari, R., Cabrini, G., & Lampronti, I. (2022). New TMA (4,6,4′-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease. International Journal of Molecular Sciences, 23(22), 14483. https://doi.org/10.3390/ijms232214483